NPI: 1518196252 · TAMPA, FL 33617 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 07/02/2009
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 07/02/2009 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 22,026 | $3.03M |
| 2019 | 34,150 | $3.92M |
| 2020 | 33,972 | $4.77M |
| 2021 | 23,012 | $1.18M |
| 2022 | 16,974 | $1.63M |
| 2023 | 1,918 | $126K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 33,682 | 2,284 | $4.82M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 46,513 | 1,948 | $4.13M |
| J1270 | Injection, doxercalciferol, 1 mcg | 24,223 | 1,570 | $2.67M |
| A4657 | Syringe, with or without needle, each | 6,138 | 2,007 | $1.06M |
| J1756 | Injection, iron sucrose, 1 mg | 8,489 | 1,624 | $618K |
| 85041 | 2,161 | 1,328 | $224K | |
| 85048 | 2,004 | 1,233 | $219K | |
| 83970 | 1,558 | 991 | $197K | |
| 83540 | 1,775 | 1,126 | $178K | |
| 82728 | 1,571 | 1,004 | $177K | |
| 83550 | 1,548 | 979 | $162K | |
| A4913 | Miscellaneous dialysis supplies, not otherwise specified | 1,560 | 773 | $99K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 372 | 154 | $49K |
| 82108 | 114 | 73 | $13K | |
| 82607 | 80 | 56 | $12K | |
| 82746 | 80 | 56 | $12K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 146 | 12 | $12K |
| 90662 | 20 | 13 | $2K | |
| G0008 | Administration of influenza virus vaccine | 18 | 14 | $1K |